Table1 Baseline clinical characteristics of the patients studied
Characteristics | Patients with atrial thrombus (n = 58) | Patients without atrial thrombus (n = 1668) | p value |
|---|---|---|---|
Male, n (%) | 39 (67.2) | 1056 (63.3) | 0.541 |
Age, years ± SD | 61.5 ± 9.7 | 59.9 ± 10.5 |  |
BMI, kg/m2 | Â | Â | 0.044* |
 ≥ 24, n (%) | 50 (86.2)* | 1243 (74.5)* |  |
 < 24, n (%) | 8 (13.8)* | 425 (25.5)* |  |
Time to AF diagnosis | Â | Â | 0.130 |
 ≥ 2 years, n (%) | 37 (63.8) | 896 (53.7) |  |
 < 2 years, n (%) | 21 (36.2) | 772 (46.3) |  |
AF type |  |  | < 0.001* |
 Paroxysmal AF, n (%) | 20 (34.5)* | 1056 (63.3)* |  |
 Persistent AF, n (%) | 38 (65.5)* | 612 (36.7)* |  |
Cancer, n (%) | 0 (0) | 11 (0.7) | 0.940 |
Coronary heart disease, n (%) | 8 (13.8) | 328 (19.7) | 0.267 |
Hyperlipidemia, n (%) | 6 (10.3) | 257 (15.4) | 0.315 |
LAD, mm | Â | Â | 0.203 |
 ≥ 40, n (%) | 34 (58.6) | 836 (50.1) |  |
 < 40, n (%) | 24 (41.4) | 832 (49.9) |  |
CHA2DS2-VASc score†|  |  | 0.485 |
 Low risk, n (%) | 34 (58.6) | 1053 (63.1) |  |
 High risk, n (%) | 24 (41.4) | 615 (36.9) |  |
Congestive heart failure, n (%) | 5 (8.6) | 82 (4.9) | 0.336 |
Hypertension, n (%) | 27 (46.6) | 769 (46.1) | 0.946 |
Diabetes mellitus, n (%) | 13 (22.4) | 244 (14.6) | 0.102 |
Stroke/TIA, n (%) | 3 (5.2) | 138 (8.3) | 0.546 |
Vascular disease, n (%) | 0 (0) | 5 (0.3) | 0.594 |
Hemorrhage, n (%) | 0 (0) | 9 (0.5) | 0.845 |
Liver dysfunction, n (%) | 1 (1.7) | 122 (7.3) | 0.172 |
Renal dysfunction, n (%) | 17 (29.3)* | 293 (17.6)* | 0.022* |
Anticoagulation, n (%) | 0 (0)* | 151 (9.0)* | 0.046* |
 Warfarin | 0 (0) | 54 (3.2) |  |
 DOAC | 0 (0) | 97 (5.8) |  |
Smoking, n (%) | 22 (37.9) | 518 (31.1) | 0.267 |
Drinking, n (%) | 18 (31.0) | 477 (28.6) | 0.687 |